Literature DB >> 27312829

[Peptic Ulcer Disease Associated with Helicobacter pylori Infection].

Se-Hwan Yeo1, Chang-Hun Yang1.   

Abstract

Although the global prevalence of peptic ulcer disease (PUD) is decreasing, PUD is still one of the most common upper gastrointestinal diseases in the world due to Helicobacter pylori infection and increased use of non-steroidal anti-inflammatory drugs. In Korea, the prevalence of H. pylori infection is also declining, but it is still the major cause of PUD. The outcomes of H. pylori infection are caused by imbalances between bacterial virulence factors, host factors, and environmental influences. In this review, we describe the prevalence trends of H. pylori infection in Korea, the mechanism of H. pylori infection-related PUD, and treatment strategies.

Entities:  

Keywords:  Epidemiology; Helicobacter pylori; Peptic ulcer; Prevalence; Therapy

Mesh:

Substances:

Year:  2016        PMID: 27312829     DOI: 10.4166/kjg.2016.67.6.289

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  4 in total

1.  Clinical Significance of Risk Factors for Asymptomatic Peptic Ulcer Disease.

Authors:  Cheal Wung Huh; Byung-Wook Kim
Journal:  Clin Endosc       Date:  2017-11-30

2.  Evolution of correlation between Helicobacter pylori infection and autoimmune liver disease.

Authors:  Xin-Guo Peng; Yu-Yuan Li; Hui-Ting Chen; Yan Zhou; Jian-Guo Ma; Hong-Min Yin
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

3.  Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection.

Authors:  Gil Ho Lee; Kee Myung Lee; Sung Jae Shin; Joon Koo Kang; Choong-Kyun Noh; Jin Hong Kim; Sun Gyo Lim
Journal:  Korean J Intern Med       Date:  2020-07-31       Impact factor: 2.884

4.  Peptic ulcer does not increase the risk of dementia: A nested case control study using a national sample cohort.

Authors:  Hyo Geun Choi; Jae Seung Soh; Jae Sung Lim; Song Yong Sim; Yoon Jung Jung; Suk Woo Lee
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.